Form 4: Portage Biotech Executive Receives Stock Grant
Insider Transaction (Form 4)
Yury Mitin, See Remarks of Portage Biotech Inc., reported multiple transactions in common stock on April 29, 2026.
Summary
- Grant/award: acquired 4,944 Ordinary Shares on April 29, 2026; holds 4,944 after (Direct).
- Open-market purchase: acquired 3,657 Ordinary Shares at $3.52 ($12,873) on September 11, 2026; holds 3,657 after (Indirect).
- Open-market purchase: acquired 9,000 Ordinary Shares at $4.29 ($38,610) on September 14, 2026; holds 12,657 after (Indirect).
- Open-market sale: disposed of 393 Ordinary Shares at $4.15 ($1,631) on September 14, 2026; holds 12,264 after (Indirect).
- Grant/award: acquired 10,906 Share Options (right to buy) on May 14, 2026; holds 10,906 after (Direct).
Sentiment
Score: 6
Explanation: StockSavvy.ai notes net insider buying of $49,852 across mixed open-market transactions.
Insider Transactions
Yury Mitin — Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-04-29 | Grant/award | Ordinary Shares | 4,944 | — | — | 4,944 |
| 2026-09-11 | Open-market purchase | Ordinary Shares | 3,657 | $4 | $12.9K | 3,657 |
| 2026-09-14 | Open-market purchase | Ordinary Shares | 9,000 | $4 | $38.6K | 12,657 |
| 2026-09-14 | Open-market sale | Ordinary Shares | 393 | $4 | $1.6K | 12,264 |
| 2026-05-14 | Grant/award | Share Options (right to buy) | 10,906 | — | — | 10,906 |
Key Dates
| Date | Description |
|---|---|
| 2026-04-29 | Grant/award (4,944 shares) |
| 2026-09-11 | Open-market purchase (3,657 shares) |
| 2026-09-14 | Open-market purchase (9,000 shares) |
| 2026-09-14 | Open-market sale (393 shares) |
| 2026-05-14 | Grant/award (10,906 shares) |
Keywords
insider transaction, Form 4, ALP, Alpha Compute Corp, net buying, Yury Mitin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.